Home  About us  Contact
 

Implanted Devices (implanted + device)

Distribution by Scientific Domains
Medical Sciences83%

Selected Abstracts

Advances in Telemetry of Implanted Devices: New Opportunities,New Responsibilities

PACING AND CLINICAL ELECTROPHYSIOLOGY, Issue 6 2006
STEPHEN C. VLAY
No abstract is available for this article. [source]

Australian implantable cardiac defibrillator recipients: Quality-of-life issues

INTERNATIONAL JOURNAL OF NURSING PRACTICE, Issue 2 2002
Dianne Pelletier RN BSci(Nurs), DipEd, FRCNA, MasterSci(Soc)
Implantable cardioverter defibrillators (ICDs) have become a well-established therapy for people experiencing potentially lethal dysrhythmias. Australian recipients' quality of life and adjustment to the device over time, device-related complications, shock and associated sensations, and potential sequelae have not been widely explored. This paper reports a longitudinal prospective study of Australian ICD recipients (n = 74) to determine their responses to the device, health-related quality of life over time and shock experiences. A questionnaire designed for the study and the Medical Outcomes Trust Quality of Life Instrument, the SF36, were completed by recipients prior to and at 3 and 12 months post insertion. Results show that quality of life decreased for general health and social function between 3 and 12 months. Nearly half (49%) of the recipients received shocks within 12 months and the majority (92%) of these experienced sequelae that could make driving hazardous. Half of the population (49%) were driving at 3 months and 69% by 12 months, including 67% of those who had been shocked. Twenty-seven percent were hospitalized with device-related complications. Driving, the shock experience and rehospitalization, the shock experience and driving behaviour are significant issues for those with the implanted device. While it is a limitation of the study that partners and carers were not included, these findings will also be of interest to them. [source]

A Study on an Energy Supply Method for a Transcutaneous Energy Transmission System

ARTIFICIAL ORGANS, Issue 1 2003
Toshinaga Ozeki
Abstract: This study proposes a new type of a transcutaneous energy transmission system (TETS) that can supply electrical power for an implanted device without an external battery. In this system, the power is supplied from the floor to the shoes of the patients through coils that are set beneath the floor and the bottom of the shoes. If the patients wear the special shoes, they will be able to move freely on the specially designed floor without an external battery. Direct current (DC)-DC power efficiency was measured in the experiments, and the results showed that it varies with relative positions between the shoe and the floor coils. The results suggested that three-layered floor coils would enable the system to meet the demand for providing the required power anywhere on the floor without intermission. DC-DC power efficiency could be kept over 60% under the practical condition. It can then be concluded that the proposed system has a potential to provide better quality of life for the patients using a TETS. [source]

Hypersensitivity reactions associated with endovascular devices

CONTACT DERMATITIS, Issue 1 2008
Golara Honari
Allergic reactions to endoprostheses are uncommon and reported in association with orthopaedic, dental, endovascular and other implanted devices. Hypersensitivity reactions to the biomaterials used in endovascular prostheses are among the infrequent reactions that may lead to local or systemic complications following cardiovascular therapeutic interventions. This article reviews potential immunotoxic effects of commonly used biomaterials. Reports of putative hypersensitivity reactions to endovascular devices, including coronary stents, perforated foramen occluders, pacemakers and implantable cardioverter defibrillators are also reviewed. [source]

Laser Raman spectroscopic investigations of biodegradable vehicle of active agents eluting LVM 316 stainless steel cardiovascular stents for in vivo degradation characteristics

JOURNAL OF RAMAN SPECTROSCOPY, Issue 4 2010
S. K. Sudheer
Abstract Laser Raman spectroscopy is an effective tool for the study of biodegradable polymers, which play a vital role in the new developments in coronary implants such as stents. There is much excitement around the potential capabilities of synthetic biodegradable polymers and the effect they will have on the design and function of implanted devices. In the present investigation, heparin-conjugated biodegradable copolymers were evaluated for their durability as drug-eluting stent coatings. Laser Raman spectroscopic studies were carried out and spectra recorded and analyzed of explanted stents coated with different amounts of polymer alone, showing the existence of different levels at different quantities of polymer. The polymer was detected on every stent analyzed. On the stents coated with a thick layer of polymer, a firm layer of polymer still existed on the stent. In contrast, this layer was degraded and spread around on the stents coated with only a thin layer of the polymer. This indicates that the polymers used in the stents in the present investigation exhibit acceptable biodegradability. Such polymers can be used as efficient drug carriers, as these materials show good degradation after the stipulated period. Copyright © 2009 John Wiley & Sons, Ltd. [source]

Successful Cervical MR Scan in a Patient Several Hours after Pacemaker Implantation

PACING AND CLINICAL ELECTROPHYSIOLOGY, Issue 10 2009
DORITH GOLDSHER M.D.
Recent data showed that patients with electrical implanted devices may under certain conditions be scanned safely by magnetic resonance imaging (MRI). The device must have been in place preferably for at least 4,8 weeks [Correction added after online publication 31-Aug-2009: number of weeks has been updated.] prior to MR imaging to allow healing and pacemaker pocket formation. We report on a patient with quadriplegia and suspected epidural hematoma referred for MR scan a day after he had a pacemaker implantation. The patient was also pacemaker-dependent. After considering the risk/benefit ratio in this patient, it was decided to perform the scan. The pacemaker was reprogrammed. MRI was performed under strict monitoring. A spinal cord contusion at the level of C1,3 was diagnosed. Based on the imaging findings no invasive procedure was done. Device interrogation found no change in sensing or pacing parameters or in the pacemaker's battery. At the end of the scan, the device was reprogrammed back to the initial settings. In this population, each scan should be discussed thoroughly and the risks to benefit ratio should be considered. Given appropriate precautions, in well-experienced imaging centers, MRI may be safely performed in patients with permanent cardiac electronic implantable devices. [source]